Literature DB >> 6316836

Diffuse bone marrow metastasis by glioblastoma: premortem diagnosis by peroxidase-antiperoxidase staining for glial fibrillary acidic protein.

W K Yung, S J Tepper, D F Young.   

Abstract

Extraneural metastases from malignant glioma and glioblastoma are believed to be rare. The most common sites of metastases are lung, lymph nodes, bone, and liver. We recently encountered two patients with glioblastoma multiforme who presented with pain and thrombocytopenia caused by diffuse metastasis to bone marrow. A premortem diagnosis was established in the first patient with the aid of peroxidase-antiperoxidase staining of the bone marrow biopsy specimen for glial fibrillary acidic protein, a glial-specific marker. In the second patient glial fibrillary acidic protein staining confirmed the glial nature of the primary brain tumor as well as the metastatic tumor in bone marrow. The first patient also had metastatic nodules on the pleural surface and on the fifth rib. All three metastatic foci had similar cellular morphology, suggesting selection of a population of tumor cells with extraneural metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316836     DOI: 10.1002/ana.410140514

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

Review 1.  Extraneural metastases of primary brain tumors.

Authors:  T Schweitzer; G H Vince; C Herbold; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

2.  The natural history of extracranial metastasis from glioblastoma multiforme.

Authors:  Melody Lun; Edwin Lok; Shiva Gautam; Erxi Wu; Eric T Wong
Journal:  J Neurooncol       Date:  2011-04-22       Impact factor: 4.130

3.  Distant metastases from a malignant glioma: unusual complications associated with treatment of a glioblastoma: distant metastases and focal white matter degeneration.

Authors:  J H Friedman; H M Liu; E Spremulli; P Calabresi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

Review 4.  Angiogenesis, metastasis, and endogenous inhibition.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 5.  Bone marrow metastases from glioblastoma multiforme--A case report and review of the literature.

Authors:  Vandana Rajagopalan; Francois G El Kamar; Rose Thayaparan; Michael L Grossbard
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

Review 6.  Metastatic glioblastoma: case presentations and a review of the literature.

Authors:  Gauri Kalokhe; Sean A Grimm; James P Chandler; Irene Helenowski; Alfred Rademaker; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2011-10-02       Impact factor: 4.130

7.  Lack of evidence of osteo-medullary metastases at diagnosis in patients with high grade gliomas.

Authors:  D Frappaz; A Jouvet; G S Pierre; F Giammarile; J Guyotat; R Deruty; E Jouanneau; D Ranchère-Vince
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

Review 8.  Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.

Authors:  Elena Anghileri; Anghileri Elena; Melina Castiglione; Castiglione Melina; Raffaele Nunziata; Nunziata Raffaele; Carlo Boffano; Boffano Carlo; Vittoria Nazzi; Nazzi Vittoria; Francesco Acerbi; Acerbi Francesco; Gaetano Finocchiaro; Finocchiaro Gaetano; Marica Eoli; Eoli Marica
Journal:  Neurosurg Rev       Date:  2015-07-28       Impact factor: 3.042

Review 9.  Vertebral collapse with quadraparesis due to metastatic gliobla multiforme: case report and review of the literature.

Authors:  R M Chesnut; J J Abitbol; M Chamberlain; L F Marshall
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

10.  Gamma-enolase and glial fibrillary acidic protein in nervous system tumors. An immunohistochemical study using specific monoclonal antibodies.

Authors:  P Cras; J J Martin; J Gheuens
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.